Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia

NeuroMolecular Medicine

Volumn 6, Issue 2-3, 2004, Pages 117-126

  Caccamo, D ^a   Condello, S ^a   Gorgone, G ^a   Crisafulli, G ^a   Belcastro, V ^a   Gennaro, S ^a   Striano, P ^b   Pisani, F ^a   Ientile, R ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

A1298C mutation; C677T mutation; DG DGGE; Epilepsy; Hyperhomocysteinemia; Methylenetetrahydrofolate reductase; Neurodegeneration

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTICONVULSIVE AGENT; FOLIC ACID; HOMOCYSTEINE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; EPILEPSY; FEMALE; FOLIC ACID DEFICIENCY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROPROTECTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; BASE SEQUENCE; DNA PRIMERS; EPILEPSY; FEMALE; GENOTYPE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; RISK FACTORS;

EID: 24644452601     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:6:2-3:117     Document Type: Article

References (24)

1. Cremonesi L., Carrera P., Fumagalli A., et al. (1999) Validation of double gradient denaturing gradient gel electrophoresis through multigenic retrospective analysis. Clin. Chem. 45, 35-40.
2. De Marco P., Calevo M. G., Moroni A., et al. (2002) Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J. Hum Genet. 47, 319-324.
3. Friso S., Girelli D., Trabetti E., et al. (2002) A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: relationships with C677T polymorphism and homocysteine/folate metabolism. Clin. Exp. Med. 2, 7-12.
4. Frosst P., Blom H. J., Milos R., et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10, 111-113.
5. Girelli D., Friso S., Trabetti E., et al. (1998) Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from Northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood 91, 4158-4163.
6. Gudnason V., Stansbie D., Scott J., Bowron A., Nicaud V., and Humphries S. (1998) C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group, Atherosclerosis 136, 347-354.
7. Hankey G. J. and Eikelboom J. W. (1999) Homocysteine and vascular disease. Lancet 354, 407-413.
8. Jacques P. F., Bostom A. G., Williams R. R., et al. (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 7-9.
9. Kara I., Sazci A., Ergul E., Kaya G., and Kilic G. (2003) Association of the C677T and A1298C polymorphisms in the 5,10-methylenetetrahydrofolate reductase gene in patients with migraine risk. Mol. Brain Res. 111, 84-90.
10. Mattson M. P. and Shea T. B. (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. TINS 26, 137-146.
11. Meisel C., Cascorbi I., Gerloff T., et al. (2001) Identification of six methylenete-trahydrofolate reductase (MTHFR) genotypes resulting from common polymorphisms: impact on plasma homocysteine levels and development of coronary artery disease. Atherosclerosis 154, 651-658.
12. Meulepas E. (1999) A P-value for an exact two-sided test of Hardy-Weinberg equilibrium. Biomed. J. 41, 499-505.
13. Ono H., Sakamoto A., Eguchi T., Sakura N., Noumura S., and Fujita N. (1997) Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants. Metabolism 46, 959-962.
14. Ono H., Sakamoto A., Mizoguchi N., and Sakura N. (2002) The C677T mutation in the methylenetetrahydrofolate reductase gene contributes to hyperhomocysteinemia in patients taking anticonvulsivants. Brain Dev. 24, 223-226.
15. Pepe G., Camacho Vanegas O., Giusti B., et al. (1998) Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10- methylenetetrahydrofolate reductase. Am. J. Hum. Genet. 63, 917-920.
16. Reyes-Engel A., Munoz E., Gaitan M. J., et al. (2002) Implications on human fertility of the 677C→T and 1298A→C polymorphisms of the MTHFR gene: consequences of a possible genetic selection. Mol. Hum. Reprod. 8, 952-957.
17. Rozen R. (1997) Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb. Haemost. 78, 523-526.
18. Schwaninger M., Ringleb P., Winter R., et al. (1999) Elevated plasma concentrations of homocysteine in antiepileptic drug treatment. Epilepsia 40, 345-350.
19. Stegmann K., Ziegler A., Ngo E.T., et al. (1999) Linkage disequilibrium of MTHFR genotypes 677C/ T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am. J. Med. Genet. 87, 23-29.
20. Terwillinger J. D. (1995) A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am. J. Hum. Genet. 56, 777-787.
21. van der Put N. M., Steegers-Theunissen R. P., Frosst P., et al. (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346, 1070-1071.
22. Weisberg I. S., Tran P., Christensen B., Sibani S., and Rozen R. (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 64, 169-172.
23. Yoo J. H. and Hong S. B. (1999) A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants. Metabolism 48, 1047-1051.
24. Zetterberg H., Regland B., Palmer M., et al. (2002) Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur. J. Hum. Genet. 10, 113-118.